Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Knee Surg Sports Traumatol Arthrosc ; 23(5): 1368-77, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-24146054

RESUMO

PURPOSE: To investigate whether mesenchymal stem cells (MSCs) seeded in novel polyvinyl alcohol (PVA)-chitosan composite hydrogel can provide comparable or even further improve cartilage repair outcomes as compared to previously established alginate-transplanted models. METHODS: Medial femoral condyle defect was created in both knees of twenty-four mature New Zealand white rabbits, and the animals were divided into four groups containing six animals each. After 3 weeks, the right knees were transplanted with PVA-chitosan-MSC, PVA-chitosan scaffold alone, alginate-MSC construct or alginate alone. The left knee was kept as untreated control. Animals were killed at the end of 6 months after transplantation, and the cartilage repair was assessed through Brittberg morphological score, histological grading by O'Driscoll score and quantitative glycosaminoglycan analysis. RESULTS: Morphological and histological analyses showed significant (p < 0.05) tissue repair when treated with PVA-chitosan-MSC or alginate MSC as compared to the scaffold only and untreated control. In addition, safranin O staining and the glycosaminoglycan (GAG) content were significantly higher (p < 0.05) in MSC treatment groups than in scaffold-only or untreated control group. No significant difference was observed between the PVA-chitosan-MSC- and alginate-MSC-treated groups. CONCLUSION: PVA-chitosan hydrogel seeded with mesenchymal stem cells provides comparable treatment outcomes to that of previously established alginate-MSC construct implantation. This study supports the potential use of PVA-chitosan hydrogel seeded with MSCs for clinical use in cartilage repair such as traumatic injuries.


Assuntos
Alginatos/farmacologia , Cartilagem Articular/lesões , Quitosana/farmacologia , Traumatismos do Joelho/cirurgia , Transplante de Células-Tronco Mesenquimais/métodos , Células-Tronco Mesenquimais/citologia , Álcool de Polivinil/farmacologia , Animais , Materiais Biocompatíveis/farmacologia , Modelos Animais de Doenças , Portadores de Fármacos , Ácido Glucurônico/farmacologia , Ácidos Hexurônicos/farmacologia , Hidrogéis , Traumatismos do Joelho/patologia , Coelhos
2.
Neurol Res ; 30(5): 487-92, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18953740

RESUMO

OBJECTIVE: After a spinal cord injury (SCI), most men experience fertility related problems including poor semen quality in which decreased sperm viability and motility, have been proposed to be related to the accessory sex glands dysfunction. In this study, we investigated the probable effects of SCI on the seminal vesicle epithelium in rat. METHODS: Spinal cord was injured in adult male rats by surgical transection at the level of T9. Controls received similar surgery without transection. Five days later, animals were killed and the seminal vesicles were removed, subjected to routine procedures for light and transmission electron microscopy respectively. RESULTS: Acute inflammation of the seminal vesicles including vasodilatation and migration of leukocytes to epithelium was observed through the light microscopy. Transmission electron microscopy study revealed significant changes in the experimental epithelium, such as decrease in rough endoplasmic reticulum, secretory granules and Golgi apparatus dimensions, accumulations of fat droplets and lipofuscin in the cytoplasm, euchromatinized and swelled nuclei, decrease in cell diameters, and the presence of macrophages and hollow spaces in the epithelium. The seminal vesicle of sham-operated animals showed normal morphology. DISCUSSION: Histologic evidence in this study confirms dysfunction of seminal vesicle in the acute phase of SCI. Further works are needed to follow up the reversibility of such lesions.


Assuntos
Epitélio/patologia , Epitélio/ultraestrutura , Glândulas Seminais/patologia , Traumatismos da Medula Espinal/patologia , Animais , Masculino , Microscopia Eletrônica de Transmissão/métodos , Ratos , Ratos Sprague-Dawley
3.
PeerJ ; 4: e1650, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26966647

RESUMO

Chondrogenic differentiation of mesenchymal stromal cells (MSCs) in the form of pellet culture and encapsulation in alginate beads has been widely used as conventional model for in vitro chondrogenesis. However, comparative characterization between differentiation, hypertrophic markers, cell adhesion molecule and ultrastructural changes during alginate and pellet culture has not been described. Hence, the present study was conducted comparing MSCs cultured in pellet and alginate beads with monolayer culture. qPCR was performed to assess the expression of chondrogenic, hypertrophic, and cell adhesion molecule genes, whereas transmission electron microscopy (TEM) was used to assess the ultrastructural changes. In addition, immunocytochemistry for Collagen type II and aggrecan and glycosaminoglycan (GAG) analysis were performed. Our results indicate that pellet and alginate bead cultures were necessary for chondrogenic differentiation of MSC. It also indicates that cultures using alginate bead demonstrated significantly higher (p < 0.05) chondrogenic but lower hypertrophic (p < 0.05) gene expressions as compared with pellet cultures. N-cadherin and N-CAM1 expression were up-regulated in second and third weeks of culture and were comparable between the alginate bead and pellet culture groups, respectively. TEM images demonstrated ultrastructural changes resembling cell death in pellet cultures. Our results indicate that using alginate beads, MSCs express higher chondrogenic but lower hypertrophic gene expression. Enhanced production of extracellular matrix and cell adhesion molecules was also observed in this group. These findings suggest that alginate bead culture may serve as a superior chondrogenic model, whereas pellet culture is more appropriate as a hypertrophic model of chondrogenesis.

4.
Am J Sports Med ; 40(1): 83-90, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21917609

RESUMO

BACKGROUND: Mesenchymal stem cells (MSCs) represent a promising alternative form of cell-based therapy for cartilage injury. However, the capacity of MSCs for chondrogenesis has not been fully explored. In particular, there is presently a lack of studies comparing the effectiveness of MSCs to conventional autologous chondrocyte (autoC) treatment for regeneration of full-thickness cartilage defects in vivo. HYPOTHESIS: Treatment with allogenic undifferentiated MSCs (alloMSCs) results in superior cartilage tissue regeneration profiles when compared with autoC for repair of focal articular cartilage defects. STUDY DESIGN: Controlled laboratory study. METHODS: Full-thickness articular cartilage defects were created on the weightbearing surface of the medial femoral condyles in both knees of New Zealand White rabbits (N = 30). Six weeks after the defect was induced, the right knee was treated with either alloMSCs (n = 12) or autoC (n = 18), while the left knee remained untreated (control). The rabbits were sacrificed at 6 months after treatment for assessment of cartilage tissue regeneration, which included the Brittberg morphologic score, histologic grading by O'Driscoll score, and quantitative analysis of glycosaminoglycans per total protein content. RESULTS: Apart from significantly higher Brittberg scores in the alloMSC treatment group (8.8 ± 0.8) versus the autoC treatment group (6.6 ± 0.8) (P = .04), both treatments showed similar cartilage regenerative profiles. All outcome measures were significantly higher in the treatment groups compared with their respective controls (P < .05). CONCLUSION: AlloMSCs have similar effectiveness as autoC for repair of focal cartilage defects. Both treatments resulted in superior tissue regeneration compared with untreated defects. CLINICAL RELEVANCE: The results have an implication of supporting the potential use of MSCs for cartilage repair after sports injuries or diseases, in view of similar efficacy but less patient morbidity and potential cost savings as compared with conventional autoC therapy.


Assuntos
Alginatos/farmacologia , Cartilagem Articular/lesões , Cartilagem Articular/cirurgia , Condrócitos/transplante , Traumatismos do Joelho/cirurgia , Transplante de Células-Tronco Mesenquimais/métodos , Animais , Células Cultivadas , Modelos Animais de Doenças , Glicosaminoglicanos/metabolismo , Técnicas Imunoenzimáticas , Masculino , Coelhos , Distribuição Aleatória , Transplante Autólogo , Transplante Homólogo , Cicatrização
5.
J Orthop Res ; 29(9): 1336-42, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21445989

RESUMO

Chondrogenic differentiated mesenchymal stem cells (CMSCs) have been shown to produce superior chondrogenic expression markers in vitro. However, the use of these cells in vivo has not been fully explored. In this study, in vivo assessment of cartilage repair potential between allogenic-derived chondrogenic pre-differentiated mesenchymal stem cells and undifferentiated MSCs (MSCs) were compared. Bilateral full thickness cartilage defects were created on the medial femoral condyles of 12 rabbits (n = 12). Rabbits were divided into two groups. In one group, the defects in the right knees were repaired using alginate encapsulated MSCs while in the second group, CMSCs were used. The animals were sacrificed and the repaired and control knees were assessed at 3 and 6 months after implantation. Quantitative analysis was performed by measuring the Glycosaminoglycans (GAGs)/total protein content. The mean Brittberg score was higher in the transplanted knees as compared to the untreated knee at 6 months (p < 0.05). Quantitative analysis of GAGs was consistent with these results. Histological and immunohistochemical analysis demonstrated hyaline-like cartilage regeneration in the transplanted sites. Significant differences between the histological scores based on O'Driscoll histological grading were observed between contralateral knees at both 3 and 6 months (p < 0.05). No significant differences were observed between the Britberg, O'Driscoll scores, and GAGs/total protein content when comparing defect sites treated with MSC and CMSC (p > 0.05). This study demonstrates that the use of either MSC or CMSC produced superior healing when compared to cartilage defects that were untreated. However, both cells produced comparable treatment outcomes.


Assuntos
Cartilagem Articular/patologia , Condrócitos/citologia , Transplante de Células-Tronco Mesenquimais/métodos , Células-Tronco Mesenquimais/citologia , Cicatrização/fisiologia , Animais , Células da Medula Óssea/citologia , Cartilagem Articular/lesões , Cartilagem Articular/cirurgia , Diferenciação Celular , Condrócitos/transplante , Glicosaminoglicanos/metabolismo , Masculino , Coelhos , Joelho de Quadrúpedes/lesões , Joelho de Quadrúpedes/patologia , Joelho de Quadrúpedes/cirurgia , Transplante Autólogo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA